Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease

BACKGROUND: Aspirin is the key treatment in the secondary prevention of atherosclerotic cardiovascular disease. High on-treatment platelet reactivity (HTPR) to aspirin has been reported to partially account for the enhanced risk of thrombotic events. In particular, HTPR has been described more frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenyi, Zhang, Peng, Liu, Meilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821654/
https://www.ncbi.nlm.nih.gov/pubmed/33482738
http://dx.doi.org/10.1186/s12877-021-02018-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821654/
https://www.ncbi.nlm.nih.gov/pubmed/33482738
http://dx.doi.org/10.1186/s12877-021-02018-y

Ejemplares similares